About Ouro Medicines
Ouro Medicines is a biotechnology company developing immune reset therapeutics for people living with chronic immune-mediated diseases.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-A
Global Headquarters
San Francisco, United States
Year Founded
2025
Team Size
11–50 employees
Tracked Since
Nov 8, 2026
Web & Domain Identity
Official Website
ouromedicines.com
Domain Registered Date
Undisclosed
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Company Profile
Company Milestones & Timeline
- Capital Raise
Raised $120,000,000 · Series-A
Backed by NEA
- Milestone
Company founded
San Francisco, United States
Investors & Backers
NEA
Lead
Boyu Capital
GSK
LongRiver Investments
Monograph Capital
Norwest Venture Partners
TPG
UPMC Enterprises
Funding History
Series-A equity
· Jan 10, 2025
Round backers: NEA
$120,000,000 fundraisingfox.com
Founders & Leadership
Christina Carlson
General Counsel and Chief Administrative Officer
Work email & phone locked
Unlock →
Jaideep Dudani
Founder
Work email & phone locked
Unlock →
Kevin Baker
Chief Development Officer
Work email & phone locked
Unlock →
Neely Mozaffarian
CMO and Head of Development
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allTesorai
tesorai.com
Seed Nov 2026
Commit Biologics
commitbio.com
Seed Aarhus · Nov 2026
Human Biome
human-biome.com
Series-A Warsaw · Nov 2026
MedInTech
medintech.co.kr
Series-B Seoul · Nov 2026
Ace Padel
acepadel.com
Seed Bradenton, United States · Nov 2026
Mentix
mentix.world
Pre-Seed London, United Kingdom · Nov 2026